# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-17-001203
Filing Date
2017-01-09
Accepted
2017-01-09 06:11:33
Documents
34
Period of Report
2017-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | v456526_8k.htm | 8-K | 16672
2 | EXHIBIT 99.1 | v456526_ex99-1.htm | EX-99.1 | 25233
3 | EXHIBIT 99.2 | v456526_ex99-2.htm | EX-99.2 | 33243
4 | GRAPHIC | ex99-2_01.jpg | GRAPHIC | 246524
5 | GRAPHIC | ex99-2_02.jpg | GRAPHIC | 379727
6 | GRAPHIC | ex99-2_03.jpg | GRAPHIC | 220732
7 | GRAPHIC | ex99-2_04.jpg | GRAPHIC | 183348
8 | GRAPHIC | ex99-2_05.jpg | GRAPHIC | 138689
9 | GRAPHIC | ex99-2_06.jpg | GRAPHIC | 252212
10 | GRAPHIC | ex99-2_07.jpg | GRAPHIC | 238062
11 | GRAPHIC | ex99-2_08.jpg | GRAPHIC | 337481
12 | GRAPHIC | ex99-2_09.jpg | GRAPHIC | 282531
13 | GRAPHIC | ex99-2_10.jpg | GRAPHIC | 232341
14 | GRAPHIC | ex99-2_11.jpg | GRAPHIC | 211481
15 | GRAPHIC | ex99-2_12.jpg | GRAPHIC | 184331
16 | GRAPHIC | ex99-2_13.jpg | GRAPHIC | 283924
17 | GRAPHIC | ex99-2_14.jpg | GRAPHIC | 247773
18 | GRAPHIC | ex99-2_15.jpg | GRAPHIC | 229343
19 | GRAPHIC | ex99-2_16.jpg | GRAPHIC | 225201
20 | GRAPHIC | ex99-2_17.jpg | GRAPHIC | 253244
21 | GRAPHIC | ex99-2_18.jpg | GRAPHIC | 230423
22 | GRAPHIC | ex99-2_19.jpg | GRAPHIC | 210432
23 | GRAPHIC | ex99-2_20.jpg | GRAPHIC | 257426
24 | GRAPHIC | ex99-2_21.jpg | GRAPHIC | 181631
25 | GRAPHIC | ex99-2_22.jpg | GRAPHIC | 272127
26 | GRAPHIC | ex99-2_23.jpg | GRAPHIC | 172769
27 | GRAPHIC | ex99-2_24.jpg | GRAPHIC | 222664
28 | GRAPHIC | ex99-2_25.jpg | GRAPHIC | 258462
29 | GRAPHIC | ex99-2_26.jpg | GRAPHIC | 176747
30 | GRAPHIC | ex99-2_27.jpg | GRAPHIC | 312534
31 | GRAPHIC | ex99-2_28.jpg | GRAPHIC | 280168
32 | GRAPHIC | ex99-2_29.jpg | GRAPHIC | 201818
33 | GRAPHIC | ex99-2_30.jpg | GRAPHIC | 280684
34 | GRAPHIC | ex99-2_31.jpg | GRAPHIC | 234634
| Complete submission text file | 0001144204-17-001203.txt |  | 10326194

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 17515701
SIC: 2836 Biological Products, (No Diagnostic Substances)